Search Results for: PROTEIN THERAPEUTICS MARKET Technology Advances

Articles

- 1/31/2012

Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger...

- 11/01/2011

Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...

- 10/17/2011

Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...

- 7/18/2012

Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc....

- DNA THERAPEUTICS – DNAbilize-ING Antisense

Peter Nielsen, MBA, explains how his company’s candidates are differentiated from those in development at other companies by the type of modification to the antisense molecule and the method by which it is conveyed to its target cell.

- 6/27/2012

Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...

- 6/13/2012

Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities...

- 2/20/2013

Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of...

- 7/19/2011

Catalent & Sanwa Announce Exclusive License Agreement Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have recently entered into...